United States · Platforms & data · Stocktwits
Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist
Detailed summary
Capricor and Savara face Nov.22 FDA deadlines, while Beren Therapeutics awaits a Tuesday decision on Adrabetadex.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)




